1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Global Minimally Invasive Vertebral Compression Fracture (VCF) Repair Market 2015-2019

About VCF
VCF is characterized by the collapse of one or more vertebral bodies, resulting in insistent and unbearable pain in patients. Osteoporosis, a degenerative bone disease, is the major cause of VCF among the elderly women. Metastatic spinal tumors, multiple myeloma, metastatic bone disease, and traumatic injuries are other causes of VCF. Individuals with VCF can undergo vertebroplasty and kyphoplasty to rectify the condition. Both procedures are minimally invasive and conducted on an outpatient basis. The use of two balloon devices makes kyphoplasty stand apart from vertebroplasty. The insertion and gradual inflation of these devices help restore the pre-facture shape and height of the vertebral bodies. Both these vertebral augmentation procedures lead to long-term maintenance of spinal bones injured by compression fractures, irrespective of their source. These procedures reduce pain in individuals, lessen the need for pain medications, decrease dependence on canes or other supporting devices, and help return to a relatively normal level of physical activity.

Technavio's analysts forecast the global minimally invasive vertebral compression fracture repair market to grow at a CAGR of 10.36% over the period 2015-2019.


Covered in this Report
This report covers the present scenario and the growth prospects of the global minimally invasive vertebral compression fracture repair market for the period 2015-2019. To calculate the market size, the report considers revenue generated through different types of minimally invasive procedures. The report presents the vendor landscape and a corresponding detailed analysis of the top six vendors in the market.

Technavio's report, Global Minimally Invasive Vertebral Compression Fracture Repair Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.


Key Regions
• Americas
• APAC
• EMEA


Key Vendors
• Alphatec Holdings
• CareFusion
• DePuy Synthes
• Medtronic
• Stryker
• Zimmer
Other Prominent Vendor
• AOI Medical
• Benvenue Medical
• Biomet
• Bonesupport
• Cook Medical
• Crosstrees Medical
• DFine
• Global Medical
• Vexim
• Zavation


Market Driver
• Growing Aging Population
• For a full, detailed list, view our report

Market Challenge
• High Cost of VCF Surgeries
• For a full, detailed list, view our report

Market Trend
• Growing Medical Tourism in Developing Countries
• For a full, detailed list, view our report

Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Table Of Contents

Global Minimally Invasive Vertebral Compression Fracture (VCF) Repair Market 2015-2019
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. VCFs
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08. Market Segmentation by Technology
08.1 Global Vertebroplasty Market
08.1.1 Market Size and Forecast
08.1.2 Global Vertebroplasty Market by Number of Procedures
08.2 Global Kyphoplasty Market
08.2.1 Market Size and Forecast
08.2.2 Global Kyphoplasty Market by Number of Procedures
09. Complications Associated with Vertebroplasty and Kyphoplasty
10. Cost Analysis
11. Reimbursement Scenario
11.1 Reimbursement Scenario in US
11.1.1 Codes and Payments for Outpatient Procedures (Hospitals)
11.1.2 Codes and Payment for Outpatient Procedures at ASC
11.1.3 Physician Payments for Procedures Performed at Hospital or ASC
11.1.4 Physician Payments for Procedures Performed in a Physician Office (Non-facility Setting)
11.2 Reimbursement Scenario in Other Major Countries
11.2.1 UK
11.2.2 Germany
11.2.3 Spain
11.2.4 Italy
11.2.5 France
11.2.6 Japan
12. Geographical Segmentation
12.1 Minimally Invasive VCF Repair Market in Americas
12.1.1 Market Size and Forecast
12.2 Minimally Invasive VCF Repair Market in EMEA
12.2.1 Market Size and Forecast
12.3 Minimally Invasive VCF Repair Market in APAC
12.3.1 Market Size and Forecast
13. Key Leading Countries
13.1 US
13.2 Germany
13.3 Japan
14. Buying Criteria
15. Market Growth Drivers
16. Drivers and Their Impact
17. Market Challenges
18. Impact of Drivers and Challenges
19. Market Trends
20. Trends and Their Impact
21. Vendor Landscape
21.1 Competitive Scenario
21.1.1 Key News
21.1.2 Mergers and Acquisitions
21.2 Market Share Analysis 2014
21.3 Other Prominent Vendors
22. Key Vendor Analysis
22.1 Alphatec
22.1.1 Key Facts
22.1.2 Business Overview
22.1.3 Geographical Segmentation by Revenue 2014
22.1.4 Business Strategy
22.1.5 Recent Developments
22.1.6 SWOT Analysis
22.2 CareFusion Corp.
22.2.1 Key Facts
22.2.2 Business Overview
22.2.3 Business Segmentation
22.2.4 Business Segmentation by Revenue 2012 and 2013
22.2.5 Sales by Geography
22.2.6 Business Strategy
22.2.7 Key Information
22.2.8 SWOT Analysis
22.2.9 Strengths
22.2.10 Weaknesses
22.2.11 Opportunities
22.2.12 Threats
22.3 DePuy Synthes
22.3.1 Key Facts
22.3.2 Business Overview
22.3.3 Business Segmentation
22.3.4 Business Strategy
22.3.5 Recent Developments
22.3.6 SWOT Analysis
22.4 Medtronic
22.4.1 Key Facts
22.4.2 Business Overview
22.4.3 Key Products
22.4.4 Business Segmentation by Revenue 2014
22.4.5 Cardiac and Vascular Group Segmentation by Revenue 2014
22.4.6 Restorative Therapies Group Segmentation by Revenue 2014
22.4.7 Diabetes Group Segmentation by Revenue 2014
22.4.8 Business Segmentation by Revenue 2013 and 2014
22.4.9 Cardiac and Vascular Group Segmentation by Revenue 2013 and 2014
22.4.10 Restorative Therapies Group Segmentation by Revenue 2013 and 2014
22.4.11 Diabetes Group Segmentation by Revenue 2013 and 2014
22.4.12 Geographical Segmentation by Revenue 2014
22.4.13 Business Strategy
22.4.14 Key Developments
22.4.15 SWOT Analysis
22.5 Stryker
22.5.1 Key Facts
22.5.2 Business Overview
22.5.3 Business Segmentation by Revenue 2013
22.5.4 Business Segmentation by Revenue 2012 and 2013
22.5.5 Geographical Segmentation by Revenue 2013
22.5.6 Business Strategy
22.5.7 Recent Developments
22.5.8 SWOT Analysis
22.6 Zimmer Holdings
22.6.1 Key Facts
22.6.2 Business Overview
22.6.3 Business Segmentation by Revenue 2013
22.6.4 Business Segmentation by Revenue 2012 and 2013
22.6.5 Geographical Segmentation by Revenue 2013
22.6.6 Business Strategy
22.6.7 Recent Developments
22.6.8 SWOT Analysis
23. Other Reports in this Series


List of Exhibits

Exhibit 1: Market Research Methodology
Exhibit 2: Observed and Expected Survival Rate Following VCF in Men and Women Aged ? 65 Years
Exhibit 3: Exhibit 5: Global Minimally Invasive VCF Repair Market 2014-2019 ($ million)
Exhibit 4: Global Minimally Invasive VCF Repair Market Segmentation by Technology
Exhibit 5: Various Steps in Vertebroplasty Procedure
Exhibit 6: Various Steps in Kyphoplasty Procedure
Exhibit 7: Segmentation of Global Minimally Invasive VCF Repair Market by Technology 2014-2019
Exhibit 8: Global Vertebroplasty Market 2014-2019 ($ million)
Exhibit 9: Number of Vertebroplasty Procedures 2014-2019
Exhibit 10: Global Kyphoplasty Market 2014-2019 ($ million)
Exhibit 11: Number of Kyphoplasty Procedures 2014-2019
Exhibit 12: Market Share Analysis for Vertebroplasty and Kyphoplasty
Exhibit 13: Complication Rates of Vertebroplasty and Kyphoplasty
Exhibit 14: Global Average Cost of Vertebroplasty Procedure
Exhibit 15: Global Average Cost of Kyphoplasty Procedure
Exhibit 16: Segmentation of Global Minimally Invasive VCF Repair Market by Geography 2014
Exhibit 17: Minimally Invasive VCF Repair Market in Americas 2014-2019 ($ million)
Exhibit 18: Minimally Invasive VCF Repair Market in EMEA 2014-2019 ($ million)
Exhibit 19: Minimally Invasive VCF Repair Market in APAC 2014-2019 ($ million)
Exhibit 20: Segmentation of Global Minimally Invasive VCF Repair Market by Geography 2014-2019 ($ million)
Exhibit 21: Segmentation of Global Minimally Invasive VCF Repair Market by Geography 2014-2019
Exhibit 22: YOY Growth Rate Comparison of Geographical Segments with Minimally Invasive VCF Repair Market 2014-2019
Exhibit 23: Major Drivers of Global Minimally Invasive VCF Repair Market
Exhibit 24: Percentage of Elderly Aged Above 65 in Different Regions 2012 and 2050
Exhibit 25: Estimated Percentage of Elderly Population 2012 and 2050
Exhibit 26: Major Challenges in Global Minimally Invasive VCF Repair Market
Exhibit 27: Market Trends in Global Minimally Invasive VCF Repair Market
Exhibit 28: Competitive Analysis of Global Minimally Invasive VCF Repair Market 2014
Exhibit 29: Alphatec: Geographical Segmentation by Revenue 2014
Exhibit 30: CareFusion Corp.: Business Segmentation
Exhibit 31: CareFusion Corp.: Business Segmentation by Revenue 2012 and 2013 ($ million)
Exhibit 32: CareFusion Corp.: Sales by Geography 2013
Exhibit 33: DePuy Synthes: Business Segmentation
Exhibit 34: Medtronic: Key Products
Exhibit 35: Medtronic: Business Segmentation by Revenue 2014
Exhibit 36: Medtronic: Cardiac and Vascular Group Segmentation by Revenue 2014
Exhibit 37: Medtronic: Restorative Therapies Group Segmentation by Revenue 2014
Exhibit 38: Medtronic: Diabetes Group Segmentation by Revenue 2014
Exhibit 39: Medtronic: Business Segmentation by Revenue 2013 and 2014 ($ million)
Exhibit 40: Medtronic: Cardiac and Vascular Group Segmentation by Revenue 2013 and 2014 ($ million)
Exhibit 41: Medtronic: Restorative Therapies Group Segmentation by Revenue 2013 and 2014 ($ million)
Exhibit 42: Medtronic: Diabetes Group Segmentation by Revenue 2013 and 2014 ($ million)
Exhibit 43: Medtronic: Geographical Segmentation by Revenue 2014
Exhibit 44: Stryker: Business Segmentation by Revenue 2013
Exhibit 45: Stryker: Business Segmentation by Revenue 2012 and 2013 ($ million)
Exhibit 46: Stryker: Geographical Segmentation by Revenue 2013
Exhibit 47: Zimmer Holdings: Business Segmentation by Revenue 2013
Exhibit 48: Zimmer Holdings: Business Segmentation by Revenue 2012 and 2013 ($ billion)
Exhibit 49: Zimmer Holdings: Geographical Segmentation by Revenue 2013

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market and Hypertension Statistics in Asia and the US

  • November 2016
    26 pages
  • Therapy  

    Hypertension  

    Cardiovascular ...  

  • Asia  

    United States  

    Europe  

View report >

Therapy Market in the US - Forecast

  • November 2016
    6 pages
  • Therapy  

    Opioid  

  • United States  

View report >

Mental Health Statistics in the UK

  • November 2016
    11 pages
  • Antipsychotic  

  • United Kingdom  

View report >

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.